TY  - JOUR
AU  - Eriksson, B.I.
AU  - Borris, L.
AU  - Dahl, O.E.
AU  - Fisher, W.D.
AU  - Haas, S.
AU  - Kakkar, A.K.
AU  - Kwong, L.M.
AU  - Misselwitz, F.
AU  - Turpie, A.G.
DO  - doi:10.1302/0301-620X.91BSUPP_I.0910103d
UR  - https://doi.org/10.1302/0301-620X.91BSUPP_I.0910103d
TI  - RIVAROXABAN (BAY 59-7939) – A NOVEL, ORAL, DIRECT FACTOR XA INHIBITOR – FOR PREVENTION OF VENOUS THROMBOEMBOLISM AFTER MAJOR ORTHOPAEDIC SURGERY: OVERVIEW OF THREE PHASE II TRIALS
T2  - Orthopaedic Proceedings
VL  - 91-B
IS  - SUPP_I
PY  - 2009
SP  - 103
EP  - 104
ER  -